Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanda Salutari

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Cancer Treatment Reviews|September 11, 2025
Advances in treatment strategies for low-grade serous ovarian cancerLucia Musacchio, Domenica Lorusso, Giulia Sabetta, et al.
Expert Opinion on Emerging Drugs|October 12, 2020
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancerDomenica Lorusso, Valentina Ceni, Margherita Muratore, et al.
Gynecologic Oncology|May 25, 2010
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1)Gabriella Macchia, Gabriella Ferrandina, Francesco Deodato, et al.
Therapeutic Advances in Medical Oncology|September 26, 2024
Antibody drug conjugates in recurrent or metastatic cervical cancer: a focus on tisotumab vedotin state of artFloriana Camarda, Mariachiara Paderno, Maria Chiara Cannizzaro, et al.
Gynecologic Oncology|June 19, 2013
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter studyGabriella Ferrandina, Vanda Salutari, Bruno Vincenzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancerGabriella Ferrandina, Franco Oreste Ranelletti, Francesco Legge, et al.
Anti-Cancer Drugs|August 5, 2015
A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: a multicentric Italian experienceFrancesca Martella, Vanda Salutari, Claudia Marchetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancerGabriella Ferrandina, Franco Oreste Ranelletti, Francesco Legge, et al.
Korean Journal of Radiology|May 28, 2021
Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to KnowLuca Russo, Giacomo Avesani, Benedetta Gui, et al.
Oncology Reports|July 7, 2009
Stereotactic radiotherapy in recurrent gynecological cancer: a case seriesFrancesco Deodato, Gabriella Macchia, Luca Grimaldi, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reviews|September 11, 2025
Advances in treatment strategies for low-grade serous ovarian cancerLucia Musacchio, Domenica Lorusso, Giulia Sabetta, et al.
Expert Opinion on Emerging Drugs|October 12, 2020
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancerDomenica Lorusso, Valentina Ceni, Margherita Muratore, et al.
Gynecologic Oncology|May 25, 2010
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1)Gabriella Macchia, Gabriella Ferrandina, Francesco Deodato, et al.
Therapeutic Advances in Medical Oncology|September 26, 2024
Antibody drug conjugates in recurrent or metastatic cervical cancer: a focus on tisotumab vedotin state of artFloriana Camarda, Mariachiara Paderno, Maria Chiara Cannizzaro, et al.
Gynecologic Oncology|June 19, 2013
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter studyGabriella Ferrandina, Vanda Salutari, Bruno Vincenzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancerGabriella Ferrandina, Franco Oreste Ranelletti, Francesco Legge, et al.
Anti-Cancer Drugs|August 5, 2015
A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: a multicentric Italian experienceFrancesca Martella, Vanda Salutari, Claudia Marchetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancerGabriella Ferrandina, Franco Oreste Ranelletti, Francesco Legge, et al.
Korean Journal of Radiology|May 28, 2021
Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to KnowLuca Russo, Giacomo Avesani, Benedetta Gui, et al.
Oncology Reports|July 7, 2009
Stereotactic radiotherapy in recurrent gynecological cancer: a case seriesFrancesco Deodato, Gabriella Macchia, Luca Grimaldi, et al.
Pageof 11